These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 3688632)

  • 1. Natural killer cell activity associated with human neoplasms.
    Cook JL
    Am Rev Respir Dis; 1987 Dec; 136(6):1323-4. PubMed ID: 3688632
    [No Abstract]   [Full Text] [Related]  

  • 2. Natural killer cell activity in bronchoalveolar lavage.
    Weissler JC
    Am Rev Respir Dis; 1988 May; 137(5):1244-6. PubMed ID: 3195822
    [No Abstract]   [Full Text] [Related]  

  • 3. Spontaneous lymphokine activated killer (LAK) activity in bronchoalveolar lavage cells from patients with bronchogenic carcinoma.
    Stein-Streilein J; Guffee J; Ramos M; Pitchenik AE
    Reg Immunol; 1989; 2(6):370-5. PubMed ID: 2485685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of bronchoalveolar lavage in the investigation of cell-mediated defence mechanisms against lung cancer.
    Spatafora M; Merendino AM; Chiappara G; Melis M; Volpes D; Bellia V; Bonsignore G
    Eur Respir J; 1990 Mar; 3(3):370-1. PubMed ID: 2187710
    [No Abstract]   [Full Text] [Related]  

  • 5. Lung natural killer and interleukin-2 activity in lung cancer. A pulmonary compartment of augmented natural killer activity occurs in patients with bronchogenic carcinoma.
    Pitchenik AE; Guffee J; Stein-Streilein J
    Am Rev Respir Dis; 1987 Dec; 136(6):1327-32. PubMed ID: 3500659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural killer activity is present in rat lung lavage and inhibited by lidocaine.
    Renzi PM; Ginns LC
    Immunopharmacol Immunotoxicol; 1990; 12(3):389-415. PubMed ID: 2266229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Warm ischemia induces alteration in lung immune cell functions.
    Nguyen D; Mulder DS; Shennib H
    J Thorac Cardiovasc Surg; 1991 Jun; 101(6):1030-6. PubMed ID: 2038196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural killer cells activity and neuroimmunological treatment of cancer.
    Lechin F; van der Dijs B; Lechin AE; Multhoff G; Pfister K; Hromadnikova I; Zlacka D
    Clin Cancer Res; 2004 Dec; 10(23):8120; author reply 8120-1. PubMed ID: 15585648
    [No Abstract]   [Full Text] [Related]  

  • 9. [Natural killer activity and sensitization of the lymphocytes to tissue antigens in lung cancer].
    Red'ko AA; Malygin AM; Dvaladze NA; Pleskach VA; Kutushev FKh
    Vestn Khir Im I I Grek; 1988 Feb; 140(2):12-5. PubMed ID: 3388698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of different types of interferon on the natural cellular cytotoxicity of lung cancer patients].
    Avdeev GI; Viadro MM; Leĭkin IuD; Kuznetsov VP; Trakhtenberg AKh
    Eksp Onkol; 1986; 8(3):44-6. PubMed ID: 2424715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cytotoxic action of natural killer cells on human tumor cells].
    Avdeev GI; Viadro MM; Leĭkin IuD; Timofeevskaia EA; Osipov SG
    Biull Eksp Biol Med; 1985 Apr; 99(4):471-3. PubMed ID: 3986372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of lung metastasis in mice by intravascular injection of dendritic cells and natural killer cells.
    Lv HF; Cui F; Yu CH; Deng LL; Ji JJ; Lu D; Yang Y; Wang WX; Xu YQ
    Biotechnol Lett; 2009 Nov; 31(11):1709-15. PubMed ID: 19590829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of cisplatinum (CDDP) and combined chemotherapy with CDDP on peripheral blood lymphocyte natural killer (NK) activity].
    Baba M; Shibuya M; Iizuka K; Sakai S; Hirata S; Ohtsuka M; Aoyama A; Niitani H; Koizumi K; Shohji T
    Gan To Kagaku Ryoho; 1989 Sep; 16(9):3299-302. PubMed ID: 2551255
    [No Abstract]   [Full Text] [Related]  

  • 14. Augmentation of lymphokine-activated killer cell cytotoxicity by monoclonal antibodies against human small cell lung carcinoma.
    Tong AW; Lee JC; Wang RM; Ordonez G; Stone MJ
    Cancer Res; 1989 Aug; 49(15):4103-8. PubMed ID: 2545333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The characteristics of human NKT cells in lung cancer--CD1d independent cytotoxicity against lung cancer cells by NKT cells and decreased human NKT cell response in lung cancer patients.
    Konishi J; Yamazaki K; Yokouchi H; Shinagawa N; Iwabuchi K; Nishimura M
    Hum Immunol; 2004 Nov; 65(11):1377-88. PubMed ID: 15556688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung derived surface active material (SAM) inhibits natural killer cell tumor cytotoxicity.
    Baughman RP; Strohofer S
    J Clin Lab Immunol; 1989 Feb; 28(2):51-4. PubMed ID: 2787406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Natural killer cells and adenosine deaminase activity in patients with pulmonary tuberculosis].
    Mamadbekov EN; Mamedov MK; Shikhaev IS
    Probl Tuberk; 1996; (5):39-41. PubMed ID: 8984490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in natural killer cells activity in mice bearing subcutaneously implanted Lewis lung carcinoma.
    Budzyński W
    Arch Immunol Ther Exp (Warsz); 1984; 32(2):185-9. PubMed ID: 6487051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B7-1 enhances natural killer cell-mediated cytotoxicity and inhibits tumor growth of a poorly immunogenic murine carcinoma.
    Yeh KY; Pulaski BA; Woods ML; McAdam AJ; Gaspari AA; Frelinger JG; Lord EM
    Cell Immunol; 1995 Oct; 165(2):217-24. PubMed ID: 7553886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced frequency of immunoregulatory invariant natural killer T cells in the airways of children with asthma.
    Pham-Thi N; de Blic J; Le Bourgeois M; Dy M; Scheinmann P; Leite-de-Moraes MC
    J Allergy Clin Immunol; 2006 Jan; 117(1):217-8. PubMed ID: 16387611
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.